期刊文献+

抗血小板药物在经皮冠脉介入治疗中应用的新展 被引量:2

New Advances in Antiplatelet Therapy in Percutaneous Coronary Intervention
暂未订购
导出
摘要 本文对抗血小板药物 在经皮冠脉介入治疗中应用的最新成果作一综述和展望,重点讨论在介入性心脏病领域(PTCA、支架、再狭窄、围介入期心肌梗塞和急性心肌梗塞)内抗血小板方案应用的最新进展。 This article reviews the newest results and forecasts the future of an-tiplatelet therapy in percutaneous coronary in-tervention. The most important new advances in antiplatelet regimen in the field of interven-tional cardiologv (PTCA, stent, restenosis, periprocedural myocardial infarction, and acute myocardial infarction) are also discussed.
出处 《引进国外医药技术与设备》 1999年第7期28-32,共5页
关键词 抗血小板药物 冠脉血运重建术 介入疗法 antiplatelet regimen, stent thrombosis, PTCA, restenosis, myocardial infarction
  • 相关文献

参考文献1

二级参考文献10

  • 1KUSHNER F G,HAND M,SMITH S C Jr,et al.2009 focused updates:ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J].J Am Coll Cardiol,2009,54:2205-2241.
  • 2GIBSON C M,CANNON C P,DALEY W L,et al.TIMI frame count:a quantilative method of assessing coronary artery flow[J].Circulation,1996,93:879-888.
  • 3MORISHIMA I,SONE T,OKUMURA K,et al.Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutanoues transluminal coronary angioplasty for acute myocardial infarction[J].J Am Coll Cardiol,2000,36:1202-1209.
  • 4EECKHONT E,KERN M J.The coronary no-reflow phenomenon:a review of mechanism and therapies[J].Eur Heart J,2001,22:729-739.
  • 5SVILAAS T,VLAAR P J,VAN DER HORST I C,et al.Thrombus aspiration during primary percutaneous coronary intervention[J].N Engl J Med,2008,358:557-567.
  • 6VLAAR P J,SVILAAS T,VANDER HORST I C,et al.Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS):a 1-year follow-up study[J].Lancet,2008,371:1915-1920.
  • 7LIMBRUNO U,DE CATERINA R.EMERALD,AIMI,and PROMISE:is there still a potential for embolic protection in primary PCI?[J].Eur Heart J,2006,27:1139-1145.
  • 8MONTALESCOT G,ANTONIUCCI D,KASTRATI A,et al.Abciximab in primary coronary stenting of ST-elevation myocardial infarction:a European meta-analysis on individual patients' data with long-term follow-up[J].Eur Heart J,2007,28:443-449.
  • 9DANZI G B,SESANA M,CAPUANO C,et al.Comparison in patients having primary coronary angioplasty of abciximab versus tirofiban on recovery of left ventricular function[J].Am J Cardiol,2004,94:35-39.
  • 10NICCOLI C,LANZA G A,SHAW S,et al.Endothelin-I and acute myocardial infarction:a no-reflow mediator after successful percutaneous myocardial revascularization[J].Eur Heart J,2006,27:1793-1798.

共引文献15

同被引文献10

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部